NSAC to present Brian Bowles' UFC 160 complaint uncontested at next meeting

The Nevada State Athletic Commission is proceeding with a disciplinary complaint against bantamweight Brian Bowles despite not hearing back from the fighter on his failed drug test.

Bowles’ post-fight drug screen at UFC 160 came back with a testosterone-to-epitestosterone (T/E) ratio of more than 20-1, according to the NSAC.

The commission temporarily suspended the fighter pending a formal hearing. Bowles has the right to contest the findings, but as of yet, he hasn’t responded to the complaint, NSAC Executive Director Keith Kizer told MMAjunkie.com (www.mmajunkie.com).

“He never filed an answer, so it looks to be uncontested,” wrote Kizer via email.

Regardless, the Georgia-based fighter is likely to be suspended and fined for his failed drug test at the NSAC’s next meeting, which takes place Aug. 15 in Las Vegas.

Bowles was defeated via second-round TKO in a preliminary-card bout against George Roop at UFC 160, which took place May 25 at MGM Grand Garden Arena in Las Vegas.

The NSAC tests screens all fighters at UFC events for performance-enhancers and drugs of abuse. All other fighters at the summer event came back negative.

Bowles’ final T/E ratio is unknown because he didn’t elect to have a confirming test performed on his urine sample. He did not apply for a therapeutic use exemption to use testosterone, Kizer previously said.

A former WEC champion, Bowles (10-3 MMA, 2-2 UFC) struggled with persistent injuries since transitioning from the now-defunct promotion to the UFC. His fight at UFC 160 was his first since UFC 139 in November 2011, which ended via a second-round submission loss to Urijah Faber.

For full coverage of UFC 160, check out the UFC Events section of the site.

(Pictured: Brian Bowles)